Conmed (NYSE: CNMD) reported Q1 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $295.5 million versus the consensus estimate of $266.67 million.

GUIDANCE:

Conmed sees FY2023 revenue of $1.21-1.25 billion, versus the consensus of $1.19 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.